Frontiers Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches

Reduced mitochondrial response sensitivity is involved in the anti‑apoptotic effect of dexmedetomidine pretreatment in cardiomyocytes

Intensive Care Society State of the Art (SOA) 2023 Congress Abstracts, 2023

Frontiers Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches

PDF) Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia

Emerging benefits and drawbacks of α2‐adrenoceptor agonists in the management of sepsis and critical illness - Lankadeva - 2021 - British Journal of Pharmacology - Wiley Online Library

Frontiers Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches

Delirium in the Cardiac Intensive Care Unit

Dexmedetomidine in icu hashemian

PDF) Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation

PDF) Comparison of dexmedetomidine and propofol in mechanically ventilated patients with sepsis: A pilot study

PDF) The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19

JCM, Free Full-Text

Frontiers Dexmedetomidine only regimen for long-term sedation is associated with reduced vasopressor requirements in septic shock patients: A retrospective cohort study from MIMIC-IV database

Frontiers Multiple uses of dexmedetomidine in small animals: a mini review

Frontiers The role of dexmedetomidine in ARDS: an approach to non-intensive care sedation